Literature DB >> 15728857

Whither onchocerciasis control in Africa?

D R Hopkins, F O Richards, M Katabarwa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15728857

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  9 in total

1.  Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.

Authors:  Moses N Katabarwa; Albert Eyamba; Philippe Nwane; Peter Enyong; Souleymanou Yaya; Jean Baldiagaï; Théodore Kambaba Madi; Abdoulaye Yougouda; Gervais Ondobo Andze; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted.

Authors:  Moses Katabarwa; Tom Lakwo; Peace Habomugisha; Stella Agunyo; Edson Byamukama; David Oguttu; Richard Ndyomugyenyi; Ephraim Tukesiga; Galex Orukan Ochieng; Francis Abwaimo; Ambrose Onapa; Dennis W K Lwamafa; Frank Walsh; Thomas R Unnasch; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

3.  Planning to improve global health: the next decade of tuberculosis control.

Authors:  Dermot Maher; Chris Dye; Katherine Floyd; Andrea Pantoja; Knut Lonnroth; Alasdair Reid; Eva Nathanson; Thad Pennas; Uli Fruth; Jane Cunningham; Heather Ignatius; Mario C Raviglione; Irene Koek; Marcos Espinal
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

4.  Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 years of a single dose of annual treatment with ivermectin.

Authors:  Moses N Katabarwa; Tom Lakwo; Peace Habomugisha; Stella Agunyo; Edson Byamukama; David Oguttu; Ephraim Tukesiga; Dickson Unoba; Patrick Dramuke; Ambrose Onapa; Edridah M Tukahebwa; Dennis Lwamafa; Frank Walsh; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2013-05-20       Impact factor: 2.345

5.  Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.

Authors:  C S Mai; D M Hamm; M Banla; A Agossou; H Schulz-Key; C Heuschkel; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

6.  Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.

Authors:  Mamadou O Traore; Moussa D Sarr; Alioune Badji; Yiriba Bissan; Lamine Diawara; Konimba Doumbia; Soula F Goita; Lassana Konate; Kalifa Mounkoro; Amadou F Seck; Laurent Toe; Seyni Toure; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13

Review 7.  Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.

Authors:  Gebremedhin Gebrezgabiher; Zeleke Mekonnen; Delenasaw Yewhalaw; Asrat Hailu
Journal:  Infect Dis Poverty       Date:  2019-07-04       Impact factor: 10.485

8.  Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of cameroon.

Authors:  Moses N Katabarwa; Albert Eyamba; Philippe Nwane; Peter Enyong; Joseph Kamgno; Thomas Kueté; Souleymanou Yaya; Rosalie Aboutou; Léonard Mukenge; Claude Kafando; Coulibaly Siaka; Salifou Mkpouwoueiko; Demanga Ngangue; Benjamin Didier Biholong; Gervais Ondobo Andze
Journal:  J Parasitol Res       Date:  2013-04-17

9.  Infectivity of Simulium damnosum s.l. and therapeutic coverage of ivermectin distribution 10 years post treatment around Owena Dam, Ondo state, Nigeria.

Authors:  Bamidele Akinsanya; Babatunde Adewale; Adedotun Adenusi; ADimeji Lawal; Olalekan Rahman
Journal:  Braz J Infect Dis       Date:  2019-11-04       Impact factor: 3.257
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.